RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9720
-0.0180 (-1.82%)
At close: Apr 28, 2025, 4:00 PM
1.090
+0.118 (12.14%)
After-hours: Apr 28, 2025, 4:08 PM EDT
RenovoRx Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for RenovoRx stock have an average target of 7.00, with a low estimate of 3.00 and a high estimate of 11. The average target predicts an increase of 620.16% from the current stock price of 0.97.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RenovoRx stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +1,031.69% | Apr 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +208.64% | Apr 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +208.64% | Mar 27, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.25 → $9 | Strong Buy | Maintains | $8.25 → $9 | +825.93% | Dec 10, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8 → $8.25 | Strong Buy | Maintains | $8 → $8.25 | +748.77% | Sep 12, 2024 |
Financial Forecast
Revenue This Year
2.09M
from 43.00K
Increased by 4,755.81%
Revenue Next Year
6.01M
from 2.09M
Increased by 187.93%
EPS This Year
-0.30
from -0.40
EPS Next Year
-0.24
from -0.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.2M | 6.3M | 29.2M | ||
| Avg | 2.1M | 6.0M | 20.3M | ||
| Low | 2.0M | 5.7M | 11.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5,016.3% | 201.7% | 385.0% | ||
| Avg | 4,755.8% | 187.9% | 237.4% | ||
| Low | 4,458.1% | 171.6% | 95.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.30 | -0.21 | 0.09 | ||
| Avg | -0.30 | -0.24 | -0.01 | ||
| Low | -0.29 | -0.26 | -0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.